Journal of Hepatology
Volume 53, Issue 2 , Pages 307-312 , August 2010

Treatment of resistant pruritus from cholestasis with albumin dialysis: Combined analysis of patients from three centers

  • Albert Parés

      Affiliations

    • Liver Unit, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain
    • Corresponding Author InformationCorresponding author. Address: Liver Unit, Hospital Clínic, C/ Villarroel 170, 08036 Barcelona, Spain. Tel.: +34 93 2275753; fax: +34 93 4515522.
    • ,
  • Manuel Herrera

      Affiliations

    • Department of Emergencies and Critical Care, Carlos Haya University Hospital, Málaga, Spain
    • ,
  • Juan Avilés

      Affiliations

    • Department of Gastroenterology, Ntra. Sra. de la Candelaria University Hospital, Santa Cruz de Tenerife, Spain
    • ,
  • Miquel Sanz

      Affiliations

    • Liver Unit, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain
    • ,
  • Antoni Mas

      Affiliations

    • Liver Unit, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain

Received 10 November 2009 ,Revised 18 January 2010 ,Accepted 8 February 2010.

References 

  1. Bergasa NV. The pruritus of cholestasis. J Hepatol. 2005;43:1078–1088
  2. Neuberger J. Transplantation for primary biliary cirrhosis. Semin Liver Dis. 1997;17:137–146
  3. Crippin JS. Liver transplantation for cholestatic liver disease: screening and assessment of risk factors. Liver Transpl Surg. 1998;4:S2–S8
  4. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol 2009;51:237–267.
  5. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. American association for study of liver diseases. Primary biliary cirrhosis. Hepatology. 2009;50:291–308
  6. Datta DV, Sherlock S. Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology. 1966;50:323–332
  7. Bachs L, Pares A, Elena M, Piera C, Rodés J. Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet. 1989;1:574–576
  8. Bergasa NV, Alling DW, Talbot TL, Swain MG, Yurdaydin C, Turner ML, et al. Naloxone ameliorates the pruritus of cholestasis: results of a double-blind randomized placebo-controlled trial. Ann Intern Med. 1995;123:161–167
  9. Wolfhagen FH, Sternieri E, Hop WC, Vitale G, Bertolotti M, Van Buuren HR. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology. 1997;113:1264–1269
  10. Mayo MJ, Handem I, Saldana S, Jacobe H, Getachew Y, Rush AJ. Sertraline as a first-line treatment for cholestatic pruritus. Hepatology. 2007;45:666–674
  11. Hoek FJ, Grijm R, Sanders GT, Tytgat GN, Wilmink JM. Removal of bile acids from the blood by hemodialysis with a polyacrylonitril membrane: treatment of pruritus of cholestatic disease. Digestion. 1982;23:135–140
  12. Cohen LB, Ambinder EP, Wolke AM, Field SP, Schaffner F. Role of plasmapheresis in primary biliary cirrhosis. Gut. 1985;26:291–294
  13. Quintero E, Puig L, Parés A, Mazzara R, Castillo R, Rodés J. Utilidad del recambio plasmático intermitente en la cirrosis biliar primaria. Gastroenterol Hepatol. 1986;9:329–333
  14. Alallam A, Barth D, Heathcote EJ. Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports. Can J Gastroenterol. 2008;22:505–507
  15. Huster D, Schubert C, Achenbach H, Caca K, Mössner J, Berr F. Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC). Z Gastroenterol. 2001;39(Suppl. 2):13–14
  16. Sturm E, Franssen CF, Gouw A, Staels B, Boverhof R, De Knegt RJ, et al. Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC). Liver. 2002;22(Suppl. 2):72–75
  17. Mullhaupt B, Kullak-Ublick GA, Ambühl PM, Stocker R, Renner EL. Successful use of the molecular adsorbent recirculating system (MARS) in a patient with primary biliary cirrhosis (PBC) and treatment refractory pruritus. Hepatol Res. 2003;25:442–446
  18. Macia M, Avilés J, Navarro J, Morales S, García J. Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis. Am J Med. 2003;114:62–64
  19. Pares A, Cisneros L, Salmeron JM, Caballeria L, Mas A, Torras A, et al. Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol. 2004;99:1105–1110
  20. Bellmann R, Graziadei IW, Feistritzer C, Schwaighofer H, Stellaard F, Sturm E, et al. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver transpl. 2004;10:107–114
  21. Acevedo Ribó M, Moreno Planas JM, Sanz Moreno C, Rubio González EE, Rubio González E, Boullosa Graña E, et al. Therapy of intractable pruritus with MARS. Transplant Proc. 2005;37:1480–1481
  22. Saich R, Collins P, Ala A, Standish R, Hodgson H. Benign recurrent intrahepatic cholestasis with secondary renal impairment treated with extracorporeal albumin dialysis. Eur J Gastroenterol Hepatol. 2005;17:585–588
  23. Montero JL, Pozo JC, Barrera P, Fraga E, Costán G, Domínguez JL, et al. Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS). Transplant Proc. 2006;38:2511–2513
  24. Anand JS, Chodorowski Z, Hajduk A, Waldman W. Cholestasis induced by parabolan successfully treated with the molecular adsorbent recirculating system. ASAIO J. 2006;52:117–118
  25. Lemoine M, Revaux A, Francoz C, Ducarme G, Brechignac S, Jacquemin E, et al. Albumin liver dialysis as pregnancy-saving procedure in cholestatic liver disease and intractable pruritus. World J Gastroenterol. 2008;14:6572–6574
  26. Javouhey E, Ranchin B, Lachaux A, Boillot O, Martin X, Floret D, et al. Long-lasting extracorporeal albumin dialysis in a child with end-stage renal disease and severe cholestasis. Pediatr Transplant. 2009;13:235–239
  27. Rifai K, Hafer C, Rosenau J, Athmann C, Haller H, Manns M, et al. Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus). Scand J Gastroenterol. 2006;41:1212–1217
  28. Pusl T, Denk GU, Parhofer KG, Beuers U. Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis. J Hepatol. 2006;45:887–891
  29. Hofmann AF. Bile acids: trying to understand their chemistry and biology with the hope of helping patients. Hepatology. 2009;49:1403–1418
  30. Ricci P, Hofmann AF, Hagey LR, Jorgensen RA, Rolland Dickson E, et al. Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis. Dig Dis Sci. 1998;43:1292–1295
  31. Castaño G, Lucangioli S, Sookoian S, Mesquida M, Lemberg A, Di Scala M, et al. Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy. Clin Sci (Lond). 2006;110:459–465

PII: S0168-8278(10)00323-5

doi: 10.1016/j.jhep.2010.02.031

Journal of Hepatology
Volume 53, Issue 2 , Pages 307-312 , August 2010

Article Tools

* Image Usage & Resolution